Fortune Medicines Private Limited
About Fortune Medicines Private Limited
Data last updated:
Fortune Medicines Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 December 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC185878. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Praveen Singh Chauhan and Anita Singh Chauhan.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at M – 2 Yogeshwar Building Middle Circle Cannaught Place, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2017, the company reported a revenue of ₹19.49 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹81,549 (net margin -4.2%) and EBITDA of -₹60,595 (EBITDA margin -3.1%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years.
As per MCA filings, the company has open charges of ₹12 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fortune Medicines Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressM – 2 Yogeshwar Building Middle Circle Cannaught Place, New Delhi, Delhi, India – 110001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Fortune Medicines Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Fortune Medicines Private Limited
FY 2020 filings availableFortune Medicines Private Limited reported revenue of ₹19.49 Lakh (up 352% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 352% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 31%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹19.49 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹60,595 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹81,549 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -3.1% | ||
| Net Profit Margin | -4.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Fortune Medicines Private Limited, buy the company report.
Board of directors of Fortune Medicines Private Limited
Fortune Medicines has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Singh Chauhan | Director | 30 Dec 2015 | 10 Years 10 Months | Current |
| Anita Singh Chauhan | Director | 30 Sep 2019 | 7 Years 1 Months | Current |
| Komal Ranvirsingh Chauhan | Director | 30 Sep 2019 | 7 Years 1 Months | Current |
Auditor
Fortune Medicines Private Limited is audited by SHUKLA MISHRA & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHUKLA MISHRA & CO | FY 2017 | 013696C |
Shareholding
The shareholding of Fortune Medicines Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Fortune Medicines Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jan 2015 | 10549390 | Syndicate Bank | ₹12 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Fortune Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fortune Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fortune Medicines has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Fortune Medicines Private Limited, buy the company report.
Recent activity
Fortune Medicines Private Limited has 10 board changes on record since 2014: 3 appointments and 7 cessations. The latest: Lata Jaiswal ceased to be Director on 01 Oct 2019.
2 earlier events are in the company report.
Frequently asked questions
Fortune Medicines is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 December 2008 (18+ years old) and is registered under CIN U24232DL2008PTC185878.
Fortune Medicines has 3 current directors:
- Praveen Singh Chauhan - Director
- Anita Singh Chauhan - Director
- Komal Ranvirsingh Chauhan - Director
The latest financial statements of Fortune Medicines on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
No. Fortune Medicines has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Fortune Medicines is U24232DL2008PTC185878. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fortune Medicines was incorporated on 16 December 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
Lata Jaiswal ceased to be Director on 01 Oct 2019. Manish Jaiswal ceased to be Director on 01 Oct 2019. Nilesh Srivastva ceased to be Director on 01 Oct 2019. Fortune Medicines has 10 board changes on record in total.
The registered office of Fortune Medicines is at M – 2 Yogeshwar Building Middle Circle Cannaught Place, New Delhi, Delhi, India – 110001.
Fortune Medicines operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Fortune Medicines has open charges of ₹12 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
